InsiderTrades

Form 4 for CVS CVS Health

Accepted 2022-03-18 00:00:00 ET · period of report 2022-03-17 · accession 0001127602-22-009964 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-03-18 2022-03-17 CVS Shah Prem S EVP, Co-Pres of Retail M - OptEx $104.82 +2,935 62.0K +5% +$307.6K
DM 2022-03-18 2022-03-17 CVS Shah Prem S EVP, Co-Pres of Retail S - Sale+OE $106.65 -4,624 59.1K -7% -$493.1K
D 2022-03-18 2022-03-17 CVS Shah Prem S EVP, Co-Pres of Retail M - OptEx $0.00 -2,935 2,935 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-03-17 M A 2,935 $104.82 62,006.24 D — —
2 Common Common Stock 2022-03-17 S D 1,689 $106.65 59,071.24 D — —
3 Common Common Stock 2022-03-17 S D 2,935 $106.65 59,071.24 D — —
4 Derivative Stock Option 2022-03-17 M D 2,935 $0.00 2,935 D $104.82 · 2017-04-01 to 2023-04-01 2,935 Common Stock (F9) Option becomes exercisable in four equal installments commencing 04/01/2017.